xml: <clinical_study>
    <!-- This xml conforms to an XML Schema at:
      https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
    <required_header>
      <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
      <link_text>Link to the current ClinicalTrials.gov record.</link_text>
      <url>https://clinicaltrials.gov/ct2/show/NCT05968534</url>
    </required_header>
    <id_info>
      <org_study_id>361186</org_study_id>
      <nct_id>NCT05968534</nct_id>
    </id_info>
    <brief_title>MOSAIC (MOthers' AdvocateS In the Community) for Pregnant Women and Mothers of Children Under 5 With Experience of Intimate Partner Violence (MOSAIC Plus) Open Trial</brief_title>
    <acronym>MOSAIC Plus OT</acronym>
    <official_title>MOSAIC (MOthers' AdvocateS In the Community) for Pregnant Women and Mothers of Children Under 5 With Experience of Intimate Partner Violence: Open Trial</official_title>
    <sponsors>
      <lead_sponsor>
        <agency>Michigan State University</agency>
        <agency_class>Other</agency_class>
      </lead_sponsor>
    </sponsors>
    <source>Michigan State University</source>
    <oversight_info>
      <has_dmc>Yes</has_dmc>
      <is_fda_regulated_drug>No</is_fda_regulated_drug>
      <is_fda_regulated_device>No</is_fda_regulated_device>
    </oversight_info>
    <brief_summary>
      <textblock>
        The purpose of this R34 exploratory research proposal is to conduct formative work for a&#xD;
        larger randomized controlled trial (RCT) evaluating the effectiveness of the &quot;Mother&#xD;
        AdvocateS In the Community (MOSAIC) Plus&quot; intervention to reduce depressive and PTSD symptoms&#xD;
        and prevent additional IPV among pregnant women and mothers with children under 5&#xD;
        experiencing IPV. The MOSAIC Plus intervention will integrate IPT principles and skills into&#xD;
        the MOSAIC intervention in order to expand it to address consequences of IPV, including&#xD;
        depression and PTSD symptoms. The proposed open trial will enroll 15 pregnant women who&#xD;
        report experience of IPV in the past 6 months, and who screen positive for elevated&#xD;
        depressive and/or PTSD symptoms. The intervention lasts 6 months after enrollment.&#xD;
      </textblock>
    </brief_summary>
    <detailed_description>
      <textblock>
        Violence against women is a global human rights concern and a significant public health&#xD;
        challenge; 1 in 3 three women experience lifetime physical and/or sexual violence. As many as&#xD;
        5.3 million U.S. women report experiencing intimate partner violence (IPV; referring to&#xD;
        sexual or physical violence by current or former partners) annually. Depression and&#xD;
        posttraumatic stress disorder (PTSD) are the two most common mental health consequences of&#xD;
        IPV. In turn, developing depressive and PTSD symptoms after experiencing IPV increases future&#xD;
        risk of IPV3. IPV is also associated with chronic physical health problems and self-harm .&#xD;
  &#xD;
        Motherhood and pregnancy increase the risk for prolonged exposure to physical, psychological&#xD;
        and sexual IPV. With as many as 4% to 8% of pregnant women reporting IPV during pregnancy,&#xD;
        IPV can start or worsen during the perinatal period. Previous and current experience of IPV&#xD;
        is strongly associated with poor physical health, mental health and obstetric outcomes;&#xD;
        leading to increased utilization of health services11 even after the IPV ends12. There are&#xD;
        very few interventions that effectively reduce IPV among pregnant women and mothers with&#xD;
        children under 5 who report IPV. One of them, Mother AdvocateS In the Community (MOSAIC)&#xD;
        forms the basis of this proposal16. No existing intervention addresses the depressive and&#xD;
        PTSD symptoms that often follow IPV, are associated with suffering and morbidity, and&#xD;
        potentiate future IPV risk for pregnant women and mothers with children under 5 who report&#xD;
        IPV. In fact, there are not any interventions for any group of women that effectively reduce&#xD;
        both future IPV risk and common related mental health symptoms such as depression and PTSD.&#xD;
        An integrated intervention that addresses elevated symptoms of maternal depression and PTSD&#xD;
        while reducing subsequent IPV is needed.&#xD;
  &#xD;
        MOSAIC is a non-professional intervention delivered by mentor mothers from the community to&#xD;
        reduce IPV in pregnant women and mothers with children under 5. The intervention combines&#xD;
        elements of mentoring and IPV-specific support provided by mentor mothers. MOSAIC was also&#xD;
        tested in a fully-powered RCT for pregnant women and mothers with children under 5 in&#xD;
        Australia and found to reduce subsequent IPV. However, it did not significantly improve&#xD;
        depression, and PTSD symptoms were not evaluated. Given the suffering, morbidity, and&#xD;
        additional risk of IPV conferred by depressive and PTSD symptoms, the proposed study will&#xD;
        augment MOSAIC with principles of an evidence-based intervention to improve maternal mental&#xD;
        health. Interpersonal psychotherapy (IPT) is the front-line treatment for maternal&#xD;
        depression18 and has been found to reduce PTSD symptoms in the perinatal period19. IPT&#xD;
        addresses maternal mental health by helping women increase their general social support&#xD;
        systems and build communication skills and confidence to access needed resources and help.&#xD;
        IPT can be effectively delivered by lay providers. This proposal will integrate IPT&#xD;
        principles into MOSAIC to address both IPV and its mental health sequelae.&#xD;
  &#xD;
        The purpose of this R34 exploratory research proposal is to conduct formative work for a&#xD;
        larger randomized controlled trial (RCT) evaluating the effectiveness of the &quot;Mother&#xD;
        AdvocateS In the Community (MOSAIC) Plus&quot; intervention to reduce depressive and PTSD symptoms&#xD;
        and prevent additional IPV among pregnant women and mothers with children under 5&#xD;
        experiencing IPV. The MOSAIC Plus intervention will integrate IPT principles and skills into&#xD;
        the MOSAIC intervention in order to expand it to address consequences of IPV, including&#xD;
        depression and PTSD symptoms. The proposed study will enroll pregnant women who report&#xD;
        experience of IPV in the past 6 months, and who screen positive for elevated depressive&#xD;
        and/or PTSD symptoms. The intervention lasts 9 months after enrollment. Women will be&#xD;
        recruited from Obstetrics and Gynecological unit of the Hurley Medical Center and YWCA,&#xD;
        Flint. The control condition will be the original MOSAIC intervention. Study assessments will&#xD;
        take place at baseline, 3, 6 and 9 months.&#xD;
      </textblock>
    </detailed_description>
    <overall_status>Not yet recruiting</overall_status>
    <start_date type="Anticipated">July 31, 2023</start_date>
    <completion_date type="Anticipated">April 14, 2024</completion_date>
    <primary_completion_date type="Anticipated">February 28, 2024</primary_completion_date>
    <phase>N/A</phase>
    <study_type>Interventional</study_type>
    <has_expanded_access>No</has_expanded_access>
    <study_design_info>
      <allocation>N/A</allocation>
      <intervention_model>Single Group Assignment</intervention_model>
      <intervention_model_description>&quot;Mother AdvocateS In the Community (MOSAIC) Plus&quot; intervention to reduce depressive and PTSD symptoms and prevent additional IPV among pregnant women and mothers with children under 5 experiencing IPV. The MOSAIC Plus intervention will integrate IPT principles and skills into the MOSAIC intervention in order to expand it to address consequences of IPV, including depression and PTSD symptoms.</intervention_model_description>
      <primary_purpose>Other</primary_purpose>
      <masking>None (Open Label)</masking>
    </study_design_info>
    <primary_outcome>
      <measure>Acceptability</measure>
      <time_frame>9 months</time_frame>
      <description>Number of clients reporting acceptability of the proposed recruitment methods, research design, intervention training methods, and of delivering the MOSAIC Plus and MOSAIC interventions by using End of Treatment Questionnaire. The questionnaire assesses rate of recruitment and retention of participants and dropouts and rates of completion.</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Satisfaction with care</measure>
      <time_frame>9 months</time_frame>
      <description>Number of clients reporting satisfaction with care through rate of recruitment, client retention and intervention completion as reported in the Client Satisfaction Questionnaire,</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Quality of working relationship</measure>
      <time_frame>9 months</time_frame>
      <description>Evaluate therapeutic alliance by using Working Alliance Inventory-Short Revised (WAI-SR)</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Changes in depressive symptoms</measure>
      <time_frame>baseline, 3, 6 and 9 months</time_frame>
      <description>Number of participants reporting changes in depressive symptoms as assessed by Patient Health Questionnaire (PHQ-9). Scores range from 0-27. Higher scores indicate severity of depressive symptoms.</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Changes in posttraumatic stress disorder symptoms</measure>
      <time_frame>baseline, 3, 6 and 9 months</time_frame>
      <description>Number of participants reporting changes in posttraumatic stress disorder symptoms by using Davidson Trauma Scale. Higher scores indicate severity of posttraumatic stress symptoms.</description>
    </primary_outcome>
    <secondary_outcome>
      <measure>Changes in intimate partner violence</measure>
      <time_frame>baseline, 3, 6 and 9 months</time_frame>
      <description>Number of participants reporting changes in subsequent intimate partner violence by using Composite Abuse Scale. Higher scores indicate severity of intimate partner violence.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Effectiveness obtaining resources</measure>
      <time_frame>baseline, 3, 6 and 9 months</time_frame>
      <description>Number of participants reporting changes in effectiveness in obtaining resources by using Effectiveness Obtaining Resources (EOR) scale. Higher scores indicate improved effectiveness in obtaining resources.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Perceived social support</measure>
      <time_frame>baseline, 3, 6 and 9 months</time_frame>
      <description>Number of participants reporting changes in perceived social support by using The RAND social support scale (Medical Outcome Study-Social Support Survey MOS-SS). Higher scores demonstrate strength of social support.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Functioning</measure>
      <time_frame>baseline, 3, 6 and 9 months</time_frame>
      <description>Number of participants reporting changes in mental health related disability as evaluated by WHO Disability Assessment schedule-12. Higher scores demonstrate severity of mental health related disability.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Self-care and self-worth</measure>
      <time_frame>baseline, 3, 6 and 9 months</time_frame>
      <description>Number of participants reporting changes in self-care and self-worth as evaluated by self-care and self-worth scale.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>General health and wellbeing</measure>
      <time_frame>baseline, 3, 6 and 9 months</time_frame>
      <description>Number of participants reporting changes in general health and wellbeing as evaluated by the SF-36 scale. Scale ranges 0-100 and higher scores indicate better health and wellbeing.</description>
    </secondary_outcome>
    <other_outcome>
      <measure>Provider Competencies</measure>
      <time_frame>6 and 9 months</time_frame>
      <description>Number of participants reporting on competency of providers by using Competency Assessment Inventory (CAI).</description>
    </other_outcome>
    <other_outcome>
      <measure>Quality of working relationship-provider perspective</measure>
      <time_frame>3, 6 and 9 months</time_frame>
      <description>Assess the quality of working relationship by using the provider perspective section of working alliance inventory. The scale has scores ranging from 5 to 20. Higher scores indicate a better therapeutic alliance.</description>
    </other_outcome>
    <number_of_arms>1</number_of_arms>
    <enrollment type="Anticipated">15</enrollment>
    <condition>Intimate Partner Violence</condition>
    <condition>Depression</condition>
    <condition>Posttraumatic Stress Symptom</condition>
    <arm_group>
      <arm_group_label>MOSAIC Plus</arm_group_label>
      <arm_group_type>Other</arm_group_type>
      <description>This is a single-arm open-trial to evaluate and refine the feasibility and acceptability of training and recruitment methods. Data from this phase will be used to refine and inform study procedures for the subsequent RCT.</description>
    </arm_group>
    <intervention>
      <intervention_type>Behavioral</intervention_type>
      <intervention_name>MOSAIC Plus</intervention_name>
      <description>This is a single-arm study. Participants will receive the intervention is called &quot;Mother AdvocateS In the Community (MOSAIC) Plus&quot;, an intervention to reduce depressive and PTSD symptoms and prevent additional intimate partner violence among pregnant women and mothers with children under 5 experiencing IPV. The MOSAIC Plus intervention will integrate interpersonal psychotherapy principles and skills into the MOSAIC intervention in order to expand it to address consequences of IPV, including depression and PTSD symptoms.</description>
      <arm_group_label>MOSAIC Plus</arm_group_label>
    </intervention>
    <eligibility>
      <criteria>
        <textblock>
          Inclusion Criteria:&#xD;
  &#xD;
            -  Pregnant and/or are mothers of children under 5&#xD;
  &#xD;
            -  Report IPV experiences in the past 6 months (as assessed by Composite Abuse Scale)&#xD;
  &#xD;
            -  Aged 18 or above,&#xD;
  &#xD;
            -  Have elevated depressive and/or PTSD symptoms as assessed by Patient Health&#xD;
               Questionnaire (PHQ-9) with a cutoff point of ≥9, and/or the Davidson Trauma Scale&#xD;
               (DTS) with a cut-off point of ≥40.&#xD;
  &#xD;
          Exclusion Criteria:&#xD;
  &#xD;
            -  Cannot provide the name and contact information of at least two locator persons,&#xD;
  &#xD;
            -  Do not have access to any telephone,&#xD;
  &#xD;
            -  Cannot understand English well enough to understand the consent form or assessment&#xD;
               instruments when they are read aloud&#xD;
        </textblock>
      </criteria>
      <gender>Female</gender>
      <minimum_age>18 Years</minimum_age>
      <maximum_age>N/A</maximum_age>
      <healthy_volunteers>No</healthy_volunteers>
    </eligibility>
    <overall_contact>
      <last_name>Maji Debena, PhD</last_name>
      <phone>810-600-5684</phone>
      <email>debenama@msu.edu</email>
    </overall_contact>
    <overall_contact_backup>
      <last_name>Bianca Z Alexander</last_name>
      <email>donaldbi@msu.edu</email>
    </overall_contact_backup>
    <verification_date>July 2023</verification_date>
    <study_first_submitted>July 21, 2023</study_first_submitted>
    <study_first_submitted_qc>July 21, 2023</study_first_submitted_qc>
    <study_first_posted type="Actual">August 1, 2023</study_first_posted>
    <last_update_submitted>July 31, 2023</last_update_submitted>
    <last_update_submitted_qc>July 31, 2023</last_update_submitted_qc>
    <last_update_posted type="Actual">August 2, 2023</last_update_posted>
    <responsible_party>
      <responsible_party_type>Principal Investigator</responsible_party_type>
      <investigator_affiliation>Michigan State University</investigator_affiliation>
      <investigator_full_name>Maji Debena</investigator_full_name>
      <investigator_title>Assistant Professor</investigator_title>
    </responsible_party>
    <keyword>women</keyword>
    <keyword>mothers</keyword>
    <keyword>pregnant</keyword>
    <condition_browse>
      <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
      <mesh_term>Depression</mesh_term>
    </condition_browse>
    <patient_data>
      <sharing_ipd>Undecided</sharing_ipd>
    </patient_data>
    <!-- Results have not yet been posted for this study                                          -->
  </clinical_study>
  
  
text: download date: ClinicalTrials.gov processed this data on September 20, 2023
  link text: Link to the current ClinicalTrials.gov record.
  url: https://clinicaltrials.gov/ct2/show/NCT05968534
  org study id: 361186
  nct id: NCT05968534
  lead sponsor: 
  has dmc: Yes
  is fda regulated drug: No
  is fda regulated device: No
  The purpose of this R34 exploratory research proposal is to conduct formative work for a
        larger randomized controlled trial (RCT) evaluating the effectiveness of the "Mother
        AdvocateS In the Community (MOSAIC) Plus" intervention to reduce depressive and PTSD symptoms
        and prevent additional IPV among pregnant women and mothers with children under 5
        experiencing IPV. The MOSAIC Plus intervention will integrate IPT principles and skills into
        the MOSAIC intervention in order to expand it to address consequences of IPV, including
        depression and PTSD symptoms. The proposed open trial will enroll 15 pregnant women who
        report experience of IPV in the past 6 months, and who screen positive for elevated
        depressive and/or PTSD symptoms. The intervention lasts 6 months after enrollment.
  Violence against women is a global human rights concern and a significant public health
        challenge; 1 in 3 three women experience lifetime physical and/or sexual violence. As many as
        5.3 million U.S. women report experiencing intimate partner violence (IPV; referring to
        sexual or physical violence by current or former partners) annually. Depression and
        posttraumatic stress disorder (PTSD) are the two most common mental health consequences of
        IPV. In turn, developing depressive and PTSD symptoms after experiencing IPV increases future
        risk of IPV3. IPV is also associated with chronic physical health problems and self-harm .
  
        Motherhood and pregnancy increase the risk for prolonged exposure to physical, psychological
        and sexual IPV. With as many as 4% to 8% of pregnant women reporting IPV during pregnancy,
        IPV can start or worsen during the perinatal period. Previous and current experience of IPV
        is strongly associated with poor physical health, mental health and obstetric outcomes;
        leading to increased utilization of health services11 even after the IPV ends12. There are
        very few interventions that effectively reduce IPV among pregnant women and mothers with
        children under 5 who report IPV. One of them, Mother AdvocateS In the Community (MOSAIC)
        forms the basis of this proposal16. No existing intervention addresses the depressive and
        PTSD symptoms that often follow IPV, are associated with suffering and morbidity, and
        potentiate future IPV risk for pregnant women and mothers with children under 5 who report
        IPV. In fact, there are not any interventions for any group of women that effectively reduce
        both future IPV risk and common related mental health symptoms such as depression and PTSD.
        An integrated intervention that addresses elevated symptoms of maternal depression and PTSD
        while reducing subsequent IPV is needed.
  
        MOSAIC is a non-professional intervention delivered by mentor mothers from the community to
        reduce IPV in pregnant women and mothers with children under 5. The intervention combines
        elements of mentoring and IPV-specific support provided by mentor mothers. MOSAIC was also
        tested in a fully-powered RCT for pregnant women and mothers with children under 5 in
        Australia and found to reduce subsequent IPV. However, it did not significantly improve
        depression, and PTSD symptoms were not evaluated. Given the suffering, morbidity, and
        additional risk of IPV conferred by depressive and PTSD symptoms, the proposed study will
        augment MOSAIC with principles of an evidence-based intervention to improve maternal mental
        health. Interpersonal psychotherapy (IPT) is the front-line treatment for maternal
        depression18 and has been found to reduce PTSD symptoms in the perinatal period19. IPT
        addresses maternal mental health by helping women increase their general social support
        systems and build communication skills and confidence to access needed resources and help.
        IPT can be effectively delivered by lay providers. This proposal will integrate IPT
        principles into MOSAIC to address both IPV and its mental health sequelae.
  
        The purpose of this R34 exploratory research proposal is to conduct formative work for a
        larger randomized controlled trial (RCT) evaluating the effectiveness of the "Mother
        AdvocateS In the Community (MOSAIC) Plus" intervention to reduce depressive and PTSD symptoms
        and prevent additional IPV among pregnant women and mothers with children under 5
        experiencing IPV. The MOSAIC Plus intervention will integrate IPT principles and skills into
        the MOSAIC intervention in order to expand it to address consequences of IPV, including
        depression and PTSD symptoms. The proposed study will enroll pregnant women who report
        experience of IPV in the past 6 months, and who screen positive for elevated depressive
        and/or PTSD symptoms. The intervention lasts 9 months after enrollment. Women will be
        recruited from Obstetrics and Gynecological unit of the Hurley Medical Center and YWCA,
        Flint. The control condition will be the original MOSAIC intervention. Study assessments will
        take place at baseline, 3, 6 and 9 months.
  allocation: N/A
  intervention model: Single Group Assignment
  intervention model description: "Mother AdvocateS In the Community (MOSAIC) Plus" intervention to reduce depressive and PTSD symptoms and prevent additional IPV among pregnant women and mothers with children under 5 experiencing IPV. The MOSAIC Plus intervention will integrate IPT principles and skills into the MOSAIC intervention in order to expand it to address consequences of IPV, including depression and PTSD symptoms.
  primary purpose: Other
  masking: None (Open Label)
  measure: Acceptability
  time frame: 9 months
  description: Number of clients reporting acceptability of the proposed recruitment methods, research design, intervention training methods, and of delivering the MOSAIC Plus and MOSAIC interventions by using End of Treatment Questionnaire. The questionnaire assesses rate of recruitment and retention of participants and dropouts and rates of completion.
  measure: Satisfaction with care
  time frame: 9 months
  description: Number of clients reporting satisfaction with care through rate of recruitment, client retention and intervention completion as reported in the Client Satisfaction Questionnaire,
  measure: Quality of working relationship
  time frame: 9 months
  description: Evaluate therapeutic alliance by using Working Alliance Inventory-Short Revised (WAI-SR)
  measure: Changes in depressive symptoms
  time frame: baseline, 3, 6 and 9 months
  description: Number of participants reporting changes in depressive symptoms as assessed by Patient Health Questionnaire (PHQ-9). Scores range from 0-27. Higher scores indicate severity of depressive symptoms.
  measure: Changes in posttraumatic stress disorder symptoms
  time frame: baseline, 3, 6 and 9 months
  description: Number of participants reporting changes in posttraumatic stress disorder symptoms by using Davidson Trauma Scale. Higher scores indicate severity of posttraumatic stress symptoms.
  measure: Changes in intimate partner violence
  time frame: baseline, 3, 6 and 9 months
  description: Number of participants reporting changes in subsequent intimate partner violence by using Composite Abuse Scale. Higher scores indicate severity of intimate partner violence.
  measure: Effectiveness obtaining resources
  time frame: baseline, 3, 6 and 9 months
  description: Number of participants reporting changes in effectiveness in obtaining resources by using Effectiveness Obtaining Resources (EOR) scale. Higher scores indicate improved effectiveness in obtaining resources.
  measure: Perceived social support
  time frame: baseline, 3, 6 and 9 months
  description: Number of participants reporting changes in perceived social support by using The RAND social support scale (Medical Outcome Study-Social Support Survey MOS-SS). Higher scores demonstrate strength of social support.
  measure: Functioning
  time frame: baseline, 3, 6 and 9 months
  description: Number of participants reporting changes in mental health related disability as evaluated by WHO Disability Assessment schedule-12. Higher scores demonstrate severity of mental health related disability.
  measure: Self-care and self-worth
  time frame: baseline, 3, 6 and 9 months
  description: Number of participants reporting changes in self-care and self-worth as evaluated by self-care and self-worth scale.
  measure: General health and wellbeing
  time frame: baseline, 3, 6 and 9 months
  description: Number of participants reporting changes in general health and wellbeing as evaluated by the SF-36 scale. Scale ranges 0-100 and higher scores indicate better health and wellbeing.
  measure: Provider Competencies
  time frame: 6 and 9 months
  description: Number of participants reporting on competency of providers by using Competency Assessment Inventory (CAI).
  measure: Quality of working relationship-provider perspective
  time frame: 3, 6 and 9 months
  description: Assess the quality of working relationship by using the provider perspective section of working alliance inventory. The scale has scores ranging from 5 to 20. Higher scores indicate a better therapeutic alliance.
  arm group label: MOSAIC Plus
  arm group type: Other
  description: This is a single-arm open-trial to evaluate and refine the feasibility and acceptability of training and recruitment methods. Data from this phase will be used to refine and inform study procedures for the subsequent RCT.
  intervention type: Behavioral
  intervention name: MOSAIC Plus
  description: This is a single-arm study. Participants will receive the intervention is called "Mother AdvocateS In the Community (MOSAIC) Plus", an intervention to reduce depressive and PTSD symptoms and prevent additional intimate partner violence among pregnant women and mothers with children under 5 experiencing IPV. The MOSAIC Plus intervention will integrate interpersonal psychotherapy principles and skills into the MOSAIC intervention in order to expand it to address consequences of IPV, including depression and PTSD symptoms.
  arm group label: MOSAIC Plus
  criteria: 
  gender: Female
  minimum age: 18 Years
  maximum age: N/A
  healthy volunteers: No
  last name: Maji Debena, PhD
  phone: 810-600-5684
  email: debenama@msu.edu
  last name: Bianca Z Alexander
  email: donaldbi@msu.edu
  responsible party type: Principal Investigator
  investigator affiliation: Michigan State University
  investigator full name: Maji Debena
  investigator title: Assistant Professor
  mesh term: Depression
  sharing ipd: Undecided